Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 24

Trial Status

Completed7

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT00000352Phase 2Completed
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000353Phase 2Completed
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000354Phase 1Completed
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000355Phase 1Completed
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000356Phase 2Completed
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000357Phase 2Completed
Buprenorphine Maintenance for Opiate Dependence - 6
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000358Phase 1Completed
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

PDVAMC Treatment Research Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Walter Ling, M.D.

Friends Research Institute, Inc.

Moderately Similar
28 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Frederick Altice, MD

Yale University

Moderately Similar
6 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

David Fiellin, MD

Yale University

Moderately Similar
7 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Thomas R Kosten, M.D.

VA Connecticut Healthcare System

Moderately Similar
10 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

James Zacny, Ph.D.

University of Chicago

Moderately Similar
17 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Herbert Kleber, M.D.

New York State Psychiatric Institute

Moderately Similar
9 trials

Shared therapeutic areas:

Substance-Related DisordersOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Jeffrey L Schnipper, MD, MPH

Brigham and Women's Hospital

Related
8 trials

Shared therapeutic areas:

Opioid-Related Disorders
Similarity Score15%

David Balayssac

University Hospital, Clermont-Ferrand

Related
8 trials

Shared therapeutic areas:

Opioid-Related Disorders
Similarity Score15%

Charles W Gorodetzky, MD, PhD

US WorldMeds

Related
7 trials

Shared therapeutic areas:

Opioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Zev Schuman-Olivier, MD

Cambridge Health Alliance

Related
14 trials

Shared therapeutic areas:

Opioid-Related Disorders
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT00000352Phase 2PrincipalInvestigator

Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000353Phase 2PrincipalInvestigator

Trial of Buprenorphine/Naloxone for Opiate Dependence - 2

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000354Phase 1PrincipalInvestigator

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000355Phase 1PrincipalInvestigator

Effects of Buprenorphine and Naloxone in Opiate Addicts - 4

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000356Phase 2PrincipalInvestigator

Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000357Phase 2PrincipalInvestigator

Buprenorphine Maintenance for Opiate Dependence - 6

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000358Phase 1PrincipalInvestigator

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7

Opioid-Related DisordersSubstance-Related Disorders
Completed

All 7 trials loaded